Physician
Medical Oncology INC
Medical Oncology INC was paid $508K by Medicaid between Jan 2018 and Oct 2020, across 20 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 23% of everything it billed.
33Billing provider infoMEDICAL ONCOLOGY INC
CLARKSDALE, MS 38614
CLARKSDALE, MS 38614
33aNPI1629044839assigned 02/27/2006
33bProvider typeMedical Oncology Physician
28Total paid$508K
24GClaims42,444
24DCodes billed20
24AFirst – last monthJan 2018 – Oct 2020
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,665 | $145K | |
| 2019 | 14,614 | $193K | |
| 2020 | 15,165 | $171K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 23% | 3,379 | 1,450 | $117K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 3,165 | 2,823 | $109K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 15% | 3,827 | 1,517 | $78K |
| 96375 | Therapeutic injection; each additional sequential IV push | 7.8% | 5,152 | 2,190 | $40K |
| 96367 | 7.7% | 3,706 | 1,527 | $39K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 7.0% | 4,368 | 1,852 | $36K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 1,041 | 977 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.2% | 1,182 | 623 | $16K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2.3% | 3,603 | 1,470 | $12K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2.2% | 3,819 | 1,546 | $11K |
| J1750 | Injection, iron dextran, 50 mg | 2.1% | 603 | 249 | $11K |
| 96415 | 1.0% | 289 | 145 | $5K |
8 more codes
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 5,225 | $4K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 301 | $3K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,988 | $1K |
| 96417 | <1% | 28 | $435.28 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 682 | $361.11 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 32 | $120.38 |
| J9267 | Injection, paclitaxel, 1 mg | <1% | 23 | $119.00 |
| J9299 | Injection, nivolumab, 1 mg | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSULTANI, MTANIUS (AUTHORIZED OFFICIAL)
Parent organizationMEDICAL ONCOLOGY INC